NCT00386191View on ClinicalTrials.gov

Safety and Efficacy of Clopidogrel for Cerebral Infarction Treatment

PHASE4CompletedINTERVENTIONAL

Enrollment

1,110

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions

Cerebral Infarction

Interventions

DRUG

clopidogrel (SR25990C)

oral administration

Trial Locations (1)

Unknown

Sanofi-Aventis Administrative Office, Tokyo

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Sanofi

INDUSTRY